DPPA4 antibody (AA 9-254)
Quick Overview for DPPA4 antibody (AA 9-254) (ABIN1491698)
Target
See all DPPA4 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
- 
    - 
                                            Binding Specificity
- AA 9-254
- 
                                            Specificity
- Human DPPA4
- 
                                            Purification
- Protein A/G purified
- 
                                            Immunogen
- 
                        Human recombinant protein fragment corresponding to amino acids 9-254 of human DPPA4 (NP_060659) produced in E. coli.
 Type of Immunogen: Recombinant protein
- 
                                            Isotype
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Approved: Flo (1:100), WB (1:2000)
- 
                                            Comment
- 
                        Target Species of Antibody: Human 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- PBS, pH 7.3, 1 % BSA, 50 % glycerol, 0.02 % sodium azide
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handling Advice
- Minimize freezing and thawing.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
 
- 
                                            
- 
    
- 
                    
 
                                     
                                     
                                    